This topic contains a solution. Click here to go to the answer

Author Question: The three levels of dysfunction that may be evaluated in a patient with an endocrine problem are ... (Read 111 times)

Capo

  • Hero Member
  • *****
  • Posts: 545
The three levels of dysfunction that may be evaluated in a patient with an endocrine problem are primary, secondary, and tertiary.
 
  The possible defective sites that correspond to these primary, secondary, and tertiary levels of dysfunction are, respectively:
  A) Pituitary, target gland, hypothalamus
  B) Hypothalamus, target gland, pituitary
  C) Pituitary, hypothalamus, target gland
  D) Target gland, pituitary, hypothalamus
  E) Target gland, hypothalamus, pituitary

Question 2

Urinary aminolevulinic acid (ALA) levels are increased in all of the following disorders, except:
 
  A) Acute intermittent porphyria
  B) Coproporphyria
  C) Protoporphyria
  D) Variegate porphyria



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bdobbins

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

Ans: D

Answer to Question 2

Ans: C





 

Did you know?

Opium has influenced much of the world's most popular literature. The following authors were all opium users, of varying degrees: Lewis Carroll, Charles, Dickens, Arthur Conan Doyle, and Oscar Wilde.

Did you know?

Normal urine is sterile. It contains fluids, salts, and waste products. It is free of bacteria, viruses, and fungi.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Always store hazardous household chemicals in their original containers out of reach of children. These include bleach, paint, strippers and products containing turpentine, garden chemicals, oven cleaners, fondue fuels, nail polish, and nail polish remover.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library